5F SOFIA intermediate catheter in the treatment of acute ischemic stroke: A retrospective observational study.
Stroke
aspiration catheter
mechanical thrombectomy
Journal
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
ISSN: 2385-2011
Titre abrégé: Interv Neuroradiol
Pays: United States
ID NLM: 9602695
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
pmc-release:
01
10
2024
medline:
4
10
2023
pubmed:
6
8
2022
entrez:
5
8
2022
Statut:
ppublish
Résumé
We herein report our experience with the 5F SOFIA (Soft Torqueable catheter Optimized for Intracranial Access) intermediate catheter for endovascular treatment of patients with acute ischemic stroke (AIS) both in distal middle vessel occlusions (DMVOs) and in large vessel occlusions (LVOs) with unfavorable anatomy. Records of forty-seven patients undergoing endovascular thrombectomy with 5F SOFIA between September 2020 and March 2022 were retrospectively reviewed. Patients' demographic data, clinical presentation, treatment details, and complications were recorded from the medical record. The primary outcomes were successful revascularization (modified treatment in cerebral ischemia, mTICI ≥2b) and good clinical outcome at 3 months (modified rankin scale, mRS 0-2). Secondary outcomes were complication rates and switch to alternative techniques. Our institutional review board approved this study. Forty-seven patients with AIS treated with 5F SOFIA were examined. In eighteen (38%) cases the occlusion was located on a large vessel while in 29 (61.7%) on a distal-medium vessels. Median national institutes of health strokes scale (NIHSS) score was 16 at admission. Successful revascularization to mTICI 2b-3 was achieved in 14 of 18 patients (77.7%) with LVOs and in 24/29 cases with DMVOs (82.7%) respectively. mRS score 0-2 at three months (3 months-mRS 0-2) was 66.6% for LVOs and 68.9% in DMVOs respectively. Symptomatic intracranial hemorrhage (SICH) occurred in 2 (4.2%) patients. 5F SOFIA intermediate catheter could be a safe and effective treatment for AIS and a viable alternative to 6 F conventional intermediate catheters in selected cases.
Sections du résumé
BACKGROUND
BACKGROUND
We herein report our experience with the 5F SOFIA (Soft Torqueable catheter Optimized for Intracranial Access) intermediate catheter for endovascular treatment of patients with acute ischemic stroke (AIS) both in distal middle vessel occlusions (DMVOs) and in large vessel occlusions (LVOs) with unfavorable anatomy.
METHODS
METHODS
Records of forty-seven patients undergoing endovascular thrombectomy with 5F SOFIA between September 2020 and March 2022 were retrospectively reviewed. Patients' demographic data, clinical presentation, treatment details, and complications were recorded from the medical record. The primary outcomes were successful revascularization (modified treatment in cerebral ischemia, mTICI ≥2b) and good clinical outcome at 3 months (modified rankin scale, mRS 0-2). Secondary outcomes were complication rates and switch to alternative techniques. Our institutional review board approved this study.
RESULTS
RESULTS
Forty-seven patients with AIS treated with 5F SOFIA were examined. In eighteen (38%) cases the occlusion was located on a large vessel while in 29 (61.7%) on a distal-medium vessels. Median national institutes of health strokes scale (NIHSS) score was 16 at admission. Successful revascularization to mTICI 2b-3 was achieved in 14 of 18 patients (77.7%) with LVOs and in 24/29 cases with DMVOs (82.7%) respectively. mRS score 0-2 at three months (3 months-mRS 0-2) was 66.6% for LVOs and 68.9% in DMVOs respectively. Symptomatic intracranial hemorrhage (SICH) occurred in 2 (4.2%) patients.
CONCLUSION
CONCLUSIONS
5F SOFIA intermediate catheter could be a safe and effective treatment for AIS and a viable alternative to 6 F conventional intermediate catheters in selected cases.
Identifiants
pubmed: 35929099
doi: 10.1177/15910199221118145
pmc: PMC10549712
doi:
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
583-588Déclaration de conflit d'intérêts
Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Neurol Sci. 2021 Oct;42(10):4221-4224
pubmed: 33586082
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
J Neurointerv Surg. 2016 Jul;8(7):718-21
pubmed: 26071386
Stroke. 2020 Sep;51(9):2872-2884
pubmed: 32757757
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
N Engl J Med. 2015 Mar 12;372(11):1009-18
pubmed: 25671797
AJNR Am J Neuroradiol. 2018 Oct;39(10):1848-1853
pubmed: 30166434
J Neurointerv Surg. 2022 Jan;14(1):
pubmed: 33858973
J Neurosurg. 2020 Aug 14;135(1):53-63
pubmed: 32796146
Stroke. 2021 Mar;52(3):1131-1142
pubmed: 33563020
J Neurointerv Surg. 2019 Jul;11(7):647-652
pubmed: 30954938
Interv Neuroradiol. 2020 Oct;26(5):681-685
pubmed: 32830565
J Neuroradiol. 2019 Jul;46(4):231-237
pubmed: 30771378
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
J Neurointerv Surg. 2016 Jul;8(7):714-8
pubmed: 26024865
Stroke. 2019 Dec;50(12):e344-e418
pubmed: 31662037
AJNR Am J Neuroradiol. 2016 Apr;37(4):667-72
pubmed: 26564442
Stroke. 2015 Oct;46(10):2981-6
pubmed: 26330447
J Neurointerv Surg. 2019 May;11(5):439-442
pubmed: 30472671
J Neurointerv Surg. 2018 May;10(5):434-439
pubmed: 28821628
J Neurointerv Surg. 2016 Mar;8(3):247-50
pubmed: 25561585
JAMA Neurol. 2016 Nov 01;73(11):1291-1296
pubmed: 27617425
JAMA. 2016 Sep 27;316(12):1279-88
pubmed: 27673305
J Neurointerv Surg. 2020 Mar;12(3):279-282
pubmed: 31243066